Filter Results


Study status

(for at least one location)



Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 217

  • Results filtered:
  • Study status: Open/Status Unknown
  • Healthy Volunteer: Accepts healthy volunteers
Edit search filters
  1. HELP-HY: Health Education and sLeep Program in HYpertension

    Rochester, MN

  2. A Study of Tools for Standardizing Clinical Research Metadata Using HL7 FHIR

    Rochester, MN

  3. A Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck Using the da Vinci Robotic Surgical System

    Rochester, MN

  4. Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block

    Rochester, MN

  5. A Study to Estimate Genetic Risk of Breast Cancer Prior to Preventive Medication Uptake

    Albert Lea, MN, Austin, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Artisan Aphakia Lens for the Correction of Aphakia in Children

    Rochester, MN

  7. Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients

    Rochester, MN

  8. Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

    Rochester, MN

  9. Pharmacogenomics (PGx) results and clinical data for assessing current and future therapeutic relevance.

    Rochester, MN

  10. Effect of Cholecystokinin (CCK) on Gastroduodenal Activity in Humans

    Rochester, MN


Mayo Clinic Footer